A study published in Clinical Ophthalmology suggests a single application of self-retained cryopreserved amniotic membrane (CAM) can speed corneal surface recovery and help reduce symptoms of dry eye disease (DED) for up to three months.
Sign up to keep reading
Create a free Member account at NZ Optics to read this article and more.
- Read all Member articles
- Full digital magazine archive
- Early access to new articles






